BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9801997)

  • 21. A false-positive I-131 whole-body scan in chronic parotitis: a case report.
    Kim S; Park CH; Yoon SN; Hwang K
    Clin Nucl Med; 2001 Jun; 26(6):536-7. PubMed ID: 11353302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of 123I scintigraphy at 5 and 24 hours in patients with differentiated thyroid cancer.
    Shankar LK; Yamamoto AJ; Alavi A; Mandel SJ
    J Nucl Med; 2002 Jan; 43(1):72-6. PubMed ID: 11801706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. False-positive whole-body scan after I-131 therapy in a patient with intestinal scar.
    Sioka C; Dimakopoulos N; Kouraklis G; Kotsalou I; Zouboulidis A
    Clin Nucl Med; 2006 Apr; 31(4):232-3. PubMed ID: 16550026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diffuse sclerosing variant of papillary thyroid carcinoma].
    Manrique Franco K; Domínguez Fernández R; Lara Capellán JI; Renedo Pascual G; Rovira Loscos A
    Endocrinol Nutr; 2010 Dec; 57(10):500-2. PubMed ID: 20843752
    [No Abstract]   [Full Text] [Related]  

  • 25. False-positive iodine-131 whole-body scan findings in patients with differentiated thyroid carcinoma: report of 11 cases and review of the literature.
    Buton L; Morel O; Gault P; Illouz F; Rodien P; Rohmer V
    Ann Endocrinol (Paris); 2013 Jul; 74(3):221-30. PubMed ID: 23796008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. False positive 131I total body scan due to bilateral polycystic renal disease.
    Giuffrida D; Fornito MC; Pellegriti G; Regalbuto C; Vigneri G
    J Endocrinol Invest; 1997 Jun; 20(6):342-4. PubMed ID: 9294782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. False-positive findings on (131)I whole-body scans because of posttraumatic superficial scabs.
    Regalbuto C; Buscema M; Arena S; Vigneri R; Squatrito S; Pezzino V
    J Nucl Med; 2002 Feb; 43(2):207-9. PubMed ID: 11850486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spurious thyroid cancer metastasis: saliva contamination artifact in high dose iodine-131 metastases survey.
    Park HM; Tarver RD; Schauwecker DS; Burt R
    J Nucl Med; 1986 May; 27(5):634-6. PubMed ID: 3712080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Are there disadvantages in administering 131I ablation therapy in patients with differentiated thyroid carcinoma without a preablative diagnostic 131I whole-body scan?
    Salvatori M; Perotti G; Rufini V; Maussier ML; Dottorini M
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):704-10. PubMed ID: 15579184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An unusual false-positive scan in a patient with pericardial effusion.
    Geatti O; Shapiro B; Orsolon PG; Mirolo R; Di Donna A
    Clin Nucl Med; 1994 Aug; 19(8):678-82. PubMed ID: 7955744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Post-laryngectomy localization of I-131 at tracheostomy site on a total body scan.
    Kirk GA; Schulz EE
    Clin Nucl Med; 1984 Jul; 9(7):409-11. PubMed ID: 6467764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Patients treated for differentiated thyroid cancer with negative 131I whole-body scans and elevated thyroglobulin levels: a possible course].
    Gutiérrez Cardo AL; Rodríguez Rodríguez JR; Borrego Dorado I; Navarro González E; Tirado Hospital JL; Vázquez Albertino R
    Rev Esp Med Nucl; 2007; 26(3):138-45. PubMed ID: 17524307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uptake of I-131 in the biliary tract: a potential cause of a false-positive result of scintiscan.
    Carlisle M; Cortés A; McDougall IR
    Clin Nucl Med; 1998 Aug; 23(8):524-7. PubMed ID: 9712386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sensitivity of 123I whole-body scan and thyroglobulin in the detection of metastases or recurrent differentiated thyroid cancer.
    de Geus-Oei LF; Oei HY; Hennemann G; Krenning EP
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):768-74. PubMed ID: 12029550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of the efficacy of iodine-131 for thyroid ablation.
    Comtois R; Thériault C; Del Vecchio P
    J Nucl Med; 1993 Nov; 34(11):1927-30. PubMed ID: 8229236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Feasibility of low doses of I-131 for thyroid ablation in postsurgical patients with thyroid carcinoma.
    Siddiqui AR; Edmondson J; Wellman HN; Hamaker RC; Lingeman RE; Park HM; Johnston CC
    Clin Nucl Med; 1981 Apr; 6(4):158-61. PubMed ID: 7214770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. False-positive 131I whole-body scan in well-differentiated thyroid cancer patient with respiratory bronchiolitis.
    Thientunyakit T
    Clin Nucl Med; 2013 Sep; 38(9):730-4. PubMed ID: 23510883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Partial stunning in thyroid remnant after administration of scanning dose followed by 100 mCi I-131 therapy.
    Yagcloglu H; Ozalp E; Ibis E; Aras G
    Clin Nucl Med; 1996 Apr; 21(4):340. PubMed ID: 8925630
    [No Abstract]   [Full Text] [Related]  

  • 39. Nuclear imaging in the management of thyroid carcinoma.
    Cavalieri RR
    Thyroid; 1996 Oct; 6(5):485-92. PubMed ID: 8936676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Self-stunning in thyroid ablation: evidence from comparative studies of diagnostic 131I and 123I.
    Hilditch TE; Dempsey MF; Bolster AA; McMenemin RM; Reed NS
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):783-8. PubMed ID: 12029552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.